A citation-based method for searching scientific literature

Hannele Erkko, Bing Xia, Jenni Nikkilä, Johanna Schleutker, Kirsi Syrjäkoski, Arto Mannermaa, Anne Kallioniemi, Katri Pylkäs, Sanna-Maria Karppinen, Katrin Rapakko, Alexander Miron, Qing Sheng, Guilan Li, Henna Mattila, Daphne W Bell, Daniel A Haber, Mervi Grip, Mervi Reiman, Arja Jukkola-Vuorinen, Aki Mustonen, Juha Kere, Lauri A Aaltonen, Veli-Matti Kosma, Vesa Kataja, Ylermi Soini, Ronny I Drapkin, David M Livingston, Robert Winqvist. Nature 2007
Times Cited: 325



Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist, Bingjian Feng, Rachel McFarland, Tina Pesaran, Robert Huether, Holly LaDuca, Elizabeth C Chao, David E Goldgar, Jill S Dolinsky. JAMA Oncol 2017
Times Cited: 347




List of shared articles



Times cited

PALB2 germline mutations in a multi-gene panel testing cohort of 1905 breast-ovarian cancer patients in Argentina.
Ariana Gonzalez, Franco Del Greco, Laura Vargas-Roig, Bianca Brun, Gonzalo Tabares, Alejandra Mampel, Cecilia Montes, Claudia Martin, Marcela Lopez, Norma Rossi,[...]. Breast Cancer Res Treat 2022
0

Case Report: Detection of a Novel Germline PALB2 Deletion in a Young Woman With Hereditary Breast Cancer: When the Patient's Phenotype History Doesn't Lie.
Carmine De Angelis, Carmela Nardelli, Paola Concolino, Martina Pagliuca, Mario Setaro, Elisa De Paolis, Pietro De Placido, Valeria Forestieri, Giovanni Luca Scaglione, Annalisa Ranieri,[...]. Front Oncol 2021
2

Spectrum and clinical relevance of PALB2 germline mutations in 7657 Chinese BRCA1/2-negative breast cancer patients.
Yifan Wu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Ye Xu, Yuntao Xie. Breast Cancer Res Treat 2020
5

Molecular Mechanisms of PALB2 Function and Its Role in Breast Cancer Management.
Shijie Wu, Jiaojiao Zhou, Kun Zhang, Huihui Chen, Meng Luo, Yuexin Lu, Yuting Sun, Yiding Chen. Front Oncol 2020
20


The Tumor Suppressor PALB2: Inside Out.
Mandy Ducy, Laura Sesma-Sanz, Laure Guitton-Sert, Anahita Lashgari, Yuandi Gao, Nadine Brahiti, Amélie Rodrigue, Guillaume Margaillan, Marie-Christine Caron, Jacques Côté,[...]. Trends Biochem Sci 2019
69

Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patients.
Anna Nurmi, Taru A Muranen, Liisa M Pelttari, Johanna I Kiiski, Tuomas Heikkinen, Sini Lehto, Anne Kallioniemi, Johanna Schleutker, Ralf Bützow, Carl Blomqvist,[...]. Int J Cancer 2019
12

Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era.
Gabriel S Macedo, Barbara Alemar, Patricia Ashton-Prolla. Genet Mol Biol 2019
13

PALB2 c.2257C>T truncating variant is a Greek founder and is associated with high breast cancer risk.
Andromachi Vagena, Myrto Papamentzelopoulou, Despoina Kalfakakou, Panagoula Kollia, Christos Papadimitriou, Amanda Psyrri, Paraskevi Apostolou, George Fountzilas, Irene Konstantopoulou, Drakoulis Yannoukakos,[...]. J Hum Genet 2019
6

Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer.
Jan Hauke, Judit Horvath, Eva Groß, Andrea Gehrig, Ellen Honisch, Karl Hackmann, Gunnar Schmidt, Norbert Arnold, Ulrike Faust, Christian Sutter,[...]. Cancer Med 2018
75

Cancer genetics, precision prevention and a call to action.
Clare Turnbull, Amit Sud, Richard S Houlston. Nat Genet 2018
61

[PALB2, a major susceptibility gene for breast cancer].
A Piffer, E Luporsi, C Mathelin. Gynecol Obstet Fertil Senol 2018
3